Anda di halaman 1dari 76

GLOBAL BURDEN OF DISEASE AND

CURRENT ISSUES OF PUBLIC HEALTH


1

PROF KUNTORO, MD, MPH, DRPH


D E PA R T M E N T O F B I O S TAT I S T I C S A N D P O P U L AT I O N S T U D Y,
A I R L A N G G A U N I V E R S I T Y S C H O O L O F P U B L I C H E A LT H

kuntoro global health sphmu ns 2/18/2018


SUBTOPIC
2

Global Burden Of Disease


Current issues of public health
(SDGs)
Population growth
Urbanization
Climate change
kuntoro global health sphmu ns 2/18/2018
3

GLOBAL BURDERN OF DISEASE

kuntoro global health sphmu ns 2/18/2018


Definition
4

 Burden of disease is a measure used to assess and


compare the relative impact of different diseases and
injuries on populations.
 A measure, like incidence rate, prevalence rate, fertility
rate.
 For assessing and comparing.
 Impact, not output or outcome
 Relative impact, not absolute impact
 Different diseases, injuries, we add risk factors
 On population  related to population study

kuntoro global health sphmu ns 2/18/2018


5

 It quantifies health loss due to disease and


injury that remains after treatment,
rehabilitation or prevention efforts of the
health system and society generally.
 Australian Institute of Health and Welfare
(https://www.aihw.gov.au/burden-of-
disease/ - 240314)

kuntoro global health sphmu ns 2/18/2018


DISEASE, IMPACT :
INJURY

IMPACT
TREATMENT, ASSESSMENT :
REHABILITATION, HEALTH LOSS ?
PREVENTION HEALTH
IN HEALTH SYSTEM OR BENEFIT ?
SOCIETY

kuntoro global health sphmu ns 6 2/18/2018


7

 People suffered from various diseases


 Various diseases put different amount of disease burden
on populations.
 Burden of disease is burden that a particular disease
process has in a particular area as measured by cost,
morbidity, and mortality.
 Burden of disease is quantified by summary measures of
population health.

kuntoro global health sphmu ns 2/18/2018


Summary measures of population health
8

1. Health expectancy
2. Health gaps

kuntoro global health sphmu ns 2/18/2018


kuntoro global health sphmu ns 9 2/18/2018
kuntoro global health sphmu ns 10 2/18/2018
kuntoro global health sphmu ns 11 2/18/2018
kuntoro global health sphmu ns 12 2/18/2018
kuntoro global health sphmu ns 13 2/18/2018
kuntoro global health sphmu ns 14 2/18/2018
15

DISABILITY ADJUSTED LIFE YEAR (DALY)

kuntoro global health sphmu ns 2/18/2018


DALY
16

 Combining the number of years of healthy life lost due to


disability and the number of years of healthy life lost due
to premature death
 One DALY for one lost year of health life
 may be used for comparing different diseases, injuries,
and risk factors
 may compare and contrast conditions that cause few
deaths but much disability and illness with conditions
that cause many premature deaths

kuntoro global health sphmu ns 2/18/2018


DALY
17

 Formula :
 DALY = YLD + YLL
 YLD is a measure for non-fatal burden
of disease
 YLL is a measure for fatal burden of
disease

kuntoro global health sphmu ns 2/18/2018


YLL (The years of Life Lost)
18

 The number of deaths multiplied by the standard life


expectancy at the age at which death occurs.
 Formula :
 YLL = N x L
 N = number of death
 L = standard life expectancy at age of death in years
 YLL measure the incident stream of lost years of life due to
deaths, an incidence perspective has also been taken for the
calculation of YLD in the original Global Burden of Disease
Study for year 1990 and in subsequent WHO updates for years
2000 to 2004.

kuntoro global health sphmu ns 2/18/2018


YDL (The years Lost Due to Disability)
19

 To estimate YLD for a particular cause in a particular time


period, the number of incident cases in that period is
multiplied by the average duration of the disease and a
weight factor that reflects the severity of the disease on a
scale from 0 (perfect health) to 1(death).
 Formula :
 YLD = I x DW x L
 I = number of incident cases
 DW = disability weight
 L = average duration of case until remission death (years)

kuntoro global health sphmu ns 2/18/2018


Prevalence Years Lived with Disability (PYLD)
20

 Formula :
 PYLD = P x DW
 P = number of prevalent cases
 DW = disability weight

kuntoro global health sphmu ns 2/18/2018


21

 PYLD may also be calculated using the prevalence of the


disease in the study year multiplied by its disability
weight.
 Prevalent YLD provide an indication of the burden of
disease that is relevant to service utilization or
expenditure.
 Prevalent YLD reflect the burden of disability over tha
current year due to cases arising in preceding years and
persisting into the current year(that is, prevalent cases).

kuntoro global health sphmu ns 2/18/2018


Non-fatal burden:years lived with disability(YLD)
22

 Example of asthma :
 Most of impact of asthma is on physical functioning and
on the ability to perform social roles.
 For asthma, the largest component of the DALY is “years
lived with disability (YLD).
 The term “ disability” refers to health states other than
ideal good health and may be short term(ex: a day with a
common cold) or long term(ex: chronic arthritis pain).

kuntoro global health sphmu ns 2/18/2018


23

 To calculate YLD for incident cases occurring in the study


year, an estimation of the incidence of the disabling
disease or injury for the specified time period is required.
 Incident YLD are calculated by multiplying the number of
incident cases of disease by the duration of the disease
(from year of incidence to year of remission or death) and
a disability weight associated with that disease.
 Incident YLD are useful for estimating the potential
value to be gained by preventing an incident case of a
disease.

kuntoro global health sphmu ns 2/18/2018


kuntoro global health sphmu ns 24 2/18/2018
Disability weight
25

 There are several methods for developing disability


weights that reflect the burden of disease relative to other
conditions, injuries, or risk factors.
 The methods involve valuation exercises in which
participants make judgments about where a condition lies
in a continuum between perfect health and death.
 Disability weight gives indication of the severity of the
disease on a scale from 0 (perfect health) to 1 (death).

kuntoro global health sphmu ns 2/18/2018


kuntoro global health sphmu ns 26 2/18/2018
Adjustment for comorbid conditions
27

 At the same time, an individual may suffer from two or


more conditions.
 In this case, we apply disability weight corrections for
coexisting health states.
 Disability weight for each condition or health state are
generally derived in isolation and may not be summed to
account for comorbid conditions.
 Corrections for coexisting health states or “comorbidity”
must be derived empirically.

kuntoro global health sphmu ns 2/18/2018


28

 Example in Australia study : hospital data and various


surveys were used to estimate the probabilites of
coexistence for each of the possible combinations of
health states.
 They were modelled using an approach which accounted
for dependence between health states  groups of
conditions being more likely to coexist due to common
causal pathways (Begg et al., 2007)

kuntoro global health sphmu ns 2/18/2018


Fatal burden: years of life lost due to premature death(YLL)
29

 DALY may be considered as a health gap measure.


 The gap between current patterns of mortality and and an
ideal scenario where everybody survives into old age.
 Mortality gap is used for calculating the years of life lost
due to premature death (YLL).
 Mortality gap is defined by using internationally
recognized standard.
 It is provided by the Coale and Demeny West level 25 and
26 model life tables

kuntoro global health sphmu ns 2/18/2018


30

 The remaining life expectancy at each age from those


model life tables is taken as “ the ideal length of life for a
person at that age.
 To calculate YLL, each death is multiplied by this
remaining life expectancy.
 A young death is associated with the greater loss than a
death at older ages.

kuntoro global health sphmu ns 2/18/2018


kuntoro global health sphmu ns 31 2/18/2018
32

CURRENT ISSUES OF
PUBLIC HEALTH

kuntoro global health sphmu ns 2/18/2018


33

1.GLOBAL HEALTH
2. SDGs

kuntoro global health sphmu ns 2/18/2018


34

1. GLOBAL HEALTH

kuntoro global health sphmu ns 2/18/2018


35

WHAT WE ARE GOING TO DO


REGARDING TO GLOBAL HEALTH ?

kuntoro global health sphmu ns 2/18/2018


36

a) Learning about the history of global health and


public health intervention that result in the
current conditions of global health
b) Identifying the current major health problems
and threats globally
c) Recommending solutions for health workers
globally that face various health problems.

kuntoro global health sphmu ns 2/18/2018


The American Heritage Dictionary
37

 Public Health is the science and practice of protecting


and improving the health of a community as by:
Preventive medicine
Health education
Control of communicable diseases
Application of sanitary measures
Monitoring of environmental health.

kuntoro global health sphmu ns 2/18/2018


38

THE MEANINGS OF GLOBAL HEALTH

kuntoro global health sphmu ns 2/18/2018


39

 Global health talks about health in the


population setting globally.
 Global health emphasizes health condition that
may have impact on political and economic
situation globally.
 Global health includes area of study, research,
and practice that may be used for improving
health and achieving equity in health for all
people globally.
kuntoro global health sphmu ns 2/18/2018
40

 Global health deals with improving


health, reducing disparities, and
protecting against global threats
regardless national borders.
 Example in the area of mental health we
recognize Global Mental Health.

kuntoro global health sphmu ns 2/18/2018


41

 International agencies that support global


health are WHO, UNAIDS, UNICEF,World
Food Program (WFP), World Bank.
 The major initiative for improving global
health is UN Millenium Declaration 
MDGs (Millenium Development Goals)
after 2015 the world will implement
Dhaka Declaration.
kuntoro global health sphmu ns 2/18/2018
42

 Global health emphasizes determinants and


distribution of health in international contexts
from several perspectives:
 Medicine describes the pathology of diseases and
promotes prevention, diagnosis, and treatment.
 Public health emphasizes the health of
populations.
 Epidemiology helps identify risk factors and causes
of health problems.

kuntoro global health sphmu ns 2/18/2018


43

Demography provides data for policy decisions.


Economics emphasizes the cost-effectiveness
and cost-benefit approaches for the optimal
allocation of health resources.
Other social sciences such as sociology,
development studies, anthropology, cultural
studies, and law may help understand the
determinants of health in societies.

kuntoro global health sphmu ns 2/18/2018


44

MAJOR PUBLIC HEALTH PROBLEMS


AND THREATS GLOBALLY

kuntoro global health sphmu ns 2/18/2018


1. Infectious Diseases
45

Tuberculosis, including Multidrug-


resistent tuberculosis
Malaria
Childhood Pneumonia
Childhood diarrhea
New and emerging infectious diseases

kuntoro global health sphmu ns 2/18/2018


2. Transition Diseases
46

Cardiovascular disease
Obesity
Lifestyle diseases related to
smoking, alcohol, drug user
Mental and psychological
illness
kuntoro global health sphmu ns 2/18/2018
3. Health Threats
47

World hunger
Displaced and refugee populations
Maternal mortality
Motor vehicle injury and mortality
Occupational workplace safety
Landmines

kuntoro global health sphmu ns 2/18/2018


4. Health threats related to environmental and social
determinants of public health
48

oPopulation growth
oGlobal climate change and
natural disasters
oPollution (air, water)
oGovernmental corruption
kuntoro global health sphmu ns 2/18/2018
49

oPolitical instability
oRegional conflict
oNuclear threats
oBiological/chemical terrorism
oEconomic inequity
kuntoro global health sphmu ns 2/18/2018
50

NEWLY RECOGNIZED PATHOGENS OR


DISEASES SINCE 1981

kuntoro global health sphmu ns 2/18/2018


51

 Avian influenza
 Amaythamebiasis  skin infection in
immunocompromised patients (HIV/AIDS)
 Australian bat Lyssavirus
 Babesiosis  malaria-like parasitic disease
 Bartonella henselae
 Coronaviruses/Severe acute respiratory syndrome (SARS)
 Ehrlichiosis
 Hantavirus pulmonary syndrome
 Helicobacter pylorii

kuntoro global health sphmu ns 2/18/2018


52

 Hendra or equine morbilli virus


 Hepatitis C virus
 Hepatitis E virus
 HIV/AIDS
 Human herpesvirus 8
 Human herpesvirus 6
 Human T-cell lymphtropic virus 1
 Human T-cell lymphtropic virus 2

kuntoro global health sphmu ns 2/18/2018


53

Borrelia burgdoferi
Microsporidia (Encephalitozoon
cuniculi, hellem,bieneusi)
Nipah virus disease
Parvovirus B19
Variant Creutzieldt-Jacob disease
kuntoro global health sphmu ns 2/18/2018
54

VACCINE-PREVENTABLE DISEASES

kuntoro global health sphmu ns 2/18/2018


55

Diseases Year
Smallpox 1798
Rabies 1885
Typhoid 1896
Cholera 1896
Diphtheria 1923
Pertussis 1926
Tetanus 1927
Tuberculosis 1927
Influenza 1945

kuntoro global health sphmu ns 2/18/2018


56

Diseases Year
Poliomyelitis 1955
Measles 1963
Anthrax 1970
Meningitis 1975
Hepatitis B 1981
Hepatitis A 1995
Varicella 1995
Rotavirus 2006
Human papilloma virus 2005

kuntoro global health sphmu ns 2/18/2018


57

DISTRIBUTION OF SELECTED DISEASES


GLOBALLY

kuntoro global health sphmu ns 2/18/2018


58

INFECTIOUS DISEASES

kuntoro global health sphmu ns 2/18/2018


kuntoro global health sphmu ns 59 2/18/2018
kuntoro global health sphmu ns 60 2/18/2018
kuntoro global health sphmu ns 61 2/18/2018
kuntoro global health sphmu ns 62 2/18/2018
kuntoro global health sphmu ns 63 2/18/2018
kuntoro global health sphmu ns 64 2/18/2018
kuntoro global health sphmu ns 65 2/18/2018
66

CHRONIC DISEASES
AND CANCER

kuntoro global health sphmu ns 2/18/2018


kuntoro global health sphmu ns 67 2/18/2018
kuntoro global health sphmu ns 68 2/18/2018
kuntoro global health sphmu ns 69 2/18/2018
kuntoro global health sphmu ns 70 2/18/2018
kuntoro global health sphmu ns 71 2/18/2018
72

2. POST MDGs

kuntoro global health sphmu ns 2/18/2018


WORLD DEVELOPMENT IN THE FUTURE
73

 DURING 2000 – 2015 EACH COUNTRY ACHIEVES


THE GOALS DIFFERENTLY
 VARIOUS FACTORS MAY DELAY THE GOAL
ACHIEVEMENTS PARTICULARLY IN
DEVELOPING COUNTRIES
 ONE PROMINENT FACTOR IS POPULATION
DYNAMICS THAT HAS NOT YET BEEN
CONSIDERED IN THE BEGINNING OF MDGs
 IT IS PROPOSED DAKHA DECLARATION

kuntoro global health sphmu ns 2/18/2018


kuntoro global health sphmu ns 74 2/18/2018
kuntoro global health sphmu ns 75 2/18/2018
kuntoro global health sphmu ns 76 2/18/2018

Anda mungkin juga menyukai